Position in MYGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$8,825,084
+$4,689,751 QoQ
Shares Held
1,545,549
+68.2% QoQ
Ownership
1.62%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 196 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Nuveen, LLC holds $3,085,298,264 across 29 Diagnostics & Research names. MYGN ranks #20 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
5,242,679 | $998,625,494 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
1,513,180 | $758,647,924 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
484,519 | $255,070,180 | |
| 4 | NTRA |
Natera, Inc.
|
499,089 | $135,477,707 | |
| 5 | DGX |
Quest Diagnostics Inc
|
563,830 | $119,503,766 | |
| 6 | WAT |
Waters Corp /De/
|
290,613 | $108,991,497 | |
| 7 | A |
Agilent Technologies, Inc.
|
782,694 | $103,965,242 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
487,108 | $94,119,005 |
All Filings in MYGN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,825,084 | 1,545,549 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $4,135,333 | 918,963 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $7,321,980 | 1,190,566 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $5,240,996 | 724,896 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $3,924,269 | 739,034 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $10,437,176 | 1,176,683 | Shares | Defined | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||